by Haja Mo June 12, 2026 Tech Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out diseases or trigger a rush toward enhancement. Previous Story Nearly Everyone, Everywhere, Veers Left When Walking Next Story The Researcher Who Didn’t Want to Know
